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NTNG2 encodes netrin-G2, a membrane-anchored protein implicated in the molecular organization of neuronal circuitry and synaptic
organization and diversification in vertebrates. In this study, through a combination of exome sequencing and autozygosity mapping,
we have identified 16 individuals (from seven unrelated families) with ultra-rare homozygous missense variants in NTNG2; these indi-
viduals present with shared features of a neurodevelopmental disorder consisting of global developmental delay, severe to profound
intellectual disability, muscle weakness and abnormal tone, autistic features, behavioral abnormalities, and variable dysmorphisms.
The variants disrupt highly conserved residues across the protein. Functional experiments, including in silico analysis of the protein
structure, in vitro assessment of cell surface expression, and in vitro knockdown, revealed potential mechanisms of pathogenicity of
the variants, including loss of protein function and decreased neurite outgrowth. Our data indicate that appropriate expression of
NTNG2 plays an important role in neurotypical development.Based on studies in invertebrates and chicken and mouse,
netrins are considered to be the paradigmatic axon guid-
ance molecules, yet the essential role of this family of pro-
teins in humans remains unclear. Members of the classical
netrin family are secreted proteins that include UNC6 (un-
coordinated-6) in C. elegans and netrins NTN1–4 in verte-
brates.1,2 Netrin-G proteins (NTNG1 and NTNG2) are
distinct from classical netrins in that they are vertebrate-
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anchors.3 NTNG1 (MIM: 608818) and NTNG2 are predom-
inantly expressed in a non-overlapping and complemen-
tary pattern in specific neuronal subsets of the developing
and mature central nervous system.4–6 The proteins
interact with the extracellular region of their specific ne-
trin-G ligand receptors NGL-1/LRRC4C (MIM: 608817)
and NGL-2/LRRC4, respectively.7 Selectivity in binding be-
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Figure 1. Pedigrees of All Families with Affected Individuals and Variants and Segregation Findings
þ indicates wild-type allele, - indicates variant allele, P indicates proband.mediated by the interactions of three loops of the laminin
domain, and the extracellular leucine rich repeats (LRR)
domain of NGLs results in a molecular hand-clasp interac-
tion of high affinity.8
NTNG2 encodes netrin-G2, a vertebrate-specific protein
that is part of a distinct functional sub-class of the highly
conserved netrin family. The netrin family provides axonal
guidance cues during central nervous system develop-
ment.9 NTNG2 is located on 9q34.13, and the canonical
transcript consists of eight exons including seven coding
exons; it encodes a 530-amino-acid protein. NTNG2 dem-
onstrates evidence of missense constraint in the ExAC
database, with a Z score of 4.34, and review of popula-
tion-based (gnomAD) and ethnically diverse in-house
databases reveals an absence of homozygous damaging
and/or deleterious variants. Despite this constraint, its
potential role in human genetic disease is not clear. Here
we show that bi-allelic missense variants in NTNG2 cause
a distinctive neurological and behavioral disorder that
highlights the importance of this family of genes in
human nervous system development.
We have identified 16 individuals (from seven unrelated
families) who have ultra-rare bi-allelic variants in NTNG2
and who present with shared clinical features of a neurode-
velopmental disorder. Consent for clinical data and biolog-
ical material collection, use, and storage was obtained from
all participating families afterwritten informedconsentwas
provided, and studies for each family were approved by
their respective institutional review boards (see Supple-
mental Data for further details). Following genomic
DNA extraction from blood, exome sequencing, andThe American Jourhomozygosity mapping, we identified 16 individuals in
seven unrelated families from different parts of Iran (Fam-
ilies 1, 2, 3), Mexico (Family 4), Turkey (Family 5), Egypt
(Family 6), and Bangladesh (Family 7) who have a similar
clinical phenotype and have homozygous missense vari-
ants in NTNG2 (Figure S1,Table S1). Researchers and physi-
cians for all families were connected using the Gene-
Matcher/Matchmaker exchange.10,11 All families except
for Families 4 and 7 had a known history of consanguinity,
and all of the variants were segregated in the affected fam-
ilies in accordancewithMendelian expectations for a reces-
sive disease trait (Figure 1). Autozygosity mapping for Fam-
ilies 4 and 7 revealed distant relatedness, and parents of the
proband in Family 7 come from the same village (Figure S2,
Table S2). There was no evidence of neuropsychiatric disor-
ders in the heterozygous family members presented here.
Clinical features of affected individuals are presented in
Table 1. Affected individuals presented with global devel-
opmental delay with severe to profound intellectual
disability; the majority were non-verbal and non-ambula-
tory. Most individuals also had features of autism and all
were noted to have mood and/or behavioral challenges,
many of which were similar to those seen in Rett syn-
drome, such as hand stereotypy, episodes of laughing
and/or screaming, and bruxism, and in Angelman syn-
drome (Videos S1–S4). Gastrointestinal symptoms,
including constipation and bloating, were also common.
Growth parameters were below average, and four individ-
uals had documented failure to thrive. Secondary micro-
cephaly was also observed. Dysmorphic features were var-
iable and included low-set ears, hypotelorism, and frontalnal of Human Genetics 105, 1048–1056, November 7, 2019 1049
Table 1. Clinical Features of Affected Individuals
Family 1 1 2 2 2 3 3 4 4 5 5 5 5 6 6 7
Individual IV:2 IV:3 IV:1 IV:2 IV:3 IV:1 IV:2 II:1 II:2 IV:1 IV:2 IV:4 IV:5 IV:1 IV:2 II:1
Age (years) 18 10 11 16 9 15 11 11 21 11 1.25 9 5 11 8 3
Sex M F M M F F F F M M M F M M M F
ID/GDD þ þ þ þ þ þ þ þ þ þ þ þ þ þ þ þ
Motor delay þ þ þ þ þ þ þ þ þ þ þ þ þ þ þ þ
Language delay þ þ þ þ þ þ þ þ þ þ NA þ þ þ þ þ
Autistic features/stereotypy þ þ þ þ þ þ þ þ - þ NA þ þ þ - þ
Hyperactivity - þ þ þ þ - - - þ - - - - þ þ -
Screaming/laughing spells þ þ þ þ þ þ þ þ þ þ NA þ - þ - þ
Self-injury/hand-biting þ þ þ þ þ - - þ þ - - - - - - -
Bruxism - þ þ þ þ - - - - - NA þ þ þ - -
Hypotonia in infancy þ þ þ þ þ þ þ þ þ þ þ þ þ - - þ
Nonambulatory þ þ þ þ þ þ þ þ þ þ NA þ þ - - -
Brain imaging abnormalities - NA þ NA NA - þ - NA NA NA þ þ þ þ þ
Seizures - - þ - - - - þ þ - - - - þ - þ
Microcephaly - þ - þ þ - - þ NA NA - þ - - - -
Secondary Microcephaly þ NA þ NA NA
Dysmorphic features - - þ - - þ þ - - NA þ þ þ þ þ -
Ophthalmologic features - - - - - þ þ - - - - þ þ - - -
GI symptoms þ þ þ þ þ þ þ þ þ þ þ þ þ - - þ
ID/GDD, intellectual disability/global developmental delay; GI, gastrointestinal; -, absent; þ, present; NA, not ascertained/not applicablebossing (Figure 2A). Neurologically, hypotonia in infancy
and muscle weakness and/or atrophy were common find-
ings. Five individuals had early-onset seizures, and four
were noted to have ocular findings of esotropia,
nystagmus, or strabismus. Brain imaging, conducted in
both infancy and childhood, demonstrated findings
ranging from normal to mild brain atrophy with white
matter abnormalities (Figure 2B). In summary, affected in-
dividuals display a neurodevelopmental disorder of severe-
to-profound intellectual disability with marked motor
involvement and mood and behavioral challenges
including autistic features, as well as poor growth and
facial dysmorphisms. Detailed phenotypic descriptions
are provided in Table 1, Table S1, Figure 2, and the Supple-
mental Note: Case Reports in Supplemental Data.
The ultra-rare variants we identified from family based
genomic studies in the above individuals were notable
for several reasons (Table S2). All variants were absent
from both local ethnically diverse in-house databases, as
well as large population databases. Because most of the
NTNG2missense variants observed are rare to their specific
‘‘clan,’’ they may reflect variants that arose recently and ac-
cording to the clan genomics hypothesis are therefore ex-
pected to have a larger influence on disease.12 All variants
were predicted by amajority of prediction tools (FATHMM,1050 The American Journal of Human Genetics 105, 1048–1056, NovMutationAssessor, MutationTaster, PolyPhen-2, SIFT, PRO-
VEAN, and CADD) to be likely damaging to protein func-
tion, and genomic evolutionary rate profiling (GERP) indi-
cated that these sites may be under evolutionary constraint
(Table S2). In fact, all variants impact residues conserved in
NTNG1, a result that gives further evidence for the argu-
ment that they are pathogenic. Annotation of the variant
locations on the protein domains of NTNG2 revealed
that they are not confined to one domain, but they fall
within the laminin and EGF domains and are predicted
to disrupt structural motifs within NTNG2 (Figure 3A).
No other alternative candidate variants common to the
families were identified (Table S3).
The available NGL2/netrin-G2 crystal structure contains a
model of the netrin-G2 N terminus up to the first EGF
domain. We used MODELER13 to create a homology for the
EGF domains 2–4, which were not included in that crystal
structure. Using these models, we found that the variants
are located in the laminin, EGF2, or EGF4 domain
(Figure 3B–3C, Figure S3). In addition to possible effects on
specific protein-to-protein interaction sites, this suggests a
more global mechanism of functional disruption. Strikingly,
we found that four of the seven, i.e., 57% of the variants,
involve the loss or addition of cysteine residues (GenBank:
NM_032536.3: c.242G>A [p.Cys81Tyr], c.1065C>Gember 7, 2019
Figure 2. Clinical Features of Affected Individuals
(A) Representative photographs demonstrating clinical features of affected individuals; these features include facial features, muscular
atrophy, and hand stereotypy. Top row from left to right: Family 2 IV:2, IV:3, IV:1; Family 1 IV:3, IV:2. Bottom row: Family 3 IV:1,
IV:2; Family 6 IV:2, IV:1; Family 7 II:1.
(B) Representative MRIs of affected individuals, demonstrating decreased brain volume. From top to bottom: Family 6 IV:2; Family 5
IV:4; Family 5 IV:5.
(C) Bar graph summarizing proportions of various clinical findings affecting individuals.
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Figure 3. Structural Mapping and Cell Surface Expression
(A) Netrin-G2 domain overview. The positions of altered residues relative to the protein domains are indicated. Domain nomenclature is:
SP, signal peptide; b-hp, N-terminal b-hairpin domain; EGF, epidermal-growth factor like; GPIa, GPI anchor. Corresponding exons are
represented underneath the domain organization in blue.
(B) Full-length model of netrin-G2 based on the crystal structure of the Laminin-like domain and EGF18 (purple) and on homology
models of EGF2-4 (gray), in complex with its ligand NGL2 (cyan). The residues that are mutated in the presented variants are indicated
as green spheres.
(C) Close-up views of Met149 and Cys456 residues as found in the structural model shown in panel B. For close-up views of the other
mutated residues, see Figure S3.
(D) The quantification of the cell surface expression levels of wild type (WT) and mutant netrin-G2 constructs (see panel E) is shown
(mean5 SEM). The variants show significantly reduced cell-surface expression compared to the WT (****p < 0.0001).
(E) Netrin-G2 constructs were expressed in HeLa cells with an N-terminal flag tag. Flag-tagged protein was detected via cell-surface im-
munostaining (magenta). DAPI (blue) highlights cell nuclei. Representative images are shown for WT netrin-G2, untransfected cells
(negative control), p.Met149Thr and p.Cys456Tyr variants. Representative images of other variants are shown in Figure S3. Scale bar
is 15 mm.[p.Cys355Trp], c.1076C>G [p.Ser359Cys], c.1367G>A
[p.Cys456Tyr]). Given that the cysteine content of NTNG2
is only 7.9% inhumans, the enrichment for cysteine variants
in this cohort suggests amechanismof pathogenicity. Due to
the oxidizing environment in the endoplasmic reticulum
(ER) and extracellular space, cysteine residues found in extra-
cellular proteins typically appear in pairs and form disulfide
bridges. Such bridges can stabilize a protein by reducing the
entropy of the unfolded state and/or they can facilitate the
path to the native state if they link parts of a protein that
must come into contact early during a folding reaction.14
Unpaired exposed cysteines are detected by the ER quality
control machinery and targeted for refolding or degrada-
tion.14 We hypothesize that the NTNG2 variants involving
cysteine could have a negative effect on protein stability
and cell surface expression.1052 The American Journal of Human Genetics 105, 1048–1056, NovThree out of the seven variants do not involve cysteines:
c.599C>T (p.Ser200Leu), c.319T>G (p.Trp107Gly), and
c.446T>C, (p.Met149Thr). For both p.Trp107Gly and
p.Met149Thr, a large hydrophobic residue (Trp or Met) is
changed to either one lacking a side chain (Gly) or one
bearing a small polar side chain (Thr). Both of these resi-
dues form part of the hydrophobic core that stabilizes
the folding of the netrin-G2 laminin domain. Disruption
likely causes protein misfolding and lack of expression at
the cell surface. Thus the consequence of both types of var-
iants, cysteine-dependent or hydrophobic core disruptive,
is potentially a similar reduction in protein stability and
expression at the cell surface. The p.Ser200Leu variant
does not fit into either of the above categories, with
Ser200 located at the periphery of the laminin domain. It
is also located 0.9 nm away from the surface of NGL2ember 7, 2019
Figure 4. Ntng2 Knockdown in N2a Cells
(A) Knockdown of endogenousNtng2 byNtng2-specific siRNAs as normalized to control siRNA. Results of quantitative RT-PCR 30 h post-
transfection.
(B–D) Effects of Ntng2 knockdown on neurite outgrowth. Data presented as mean and SD; *p < 0.05, **p < 0.01, ***p < 0.001.
Quantification was conducted by counting the absolute number of cells with neurites (B), measuring the neurite length by NeuroLucida
tracing (C), and quantification of the Convex hull area (D). All analyses show a significant reduction of neurite number and length as a
consequence of Ntng2 knockdown.
(E–F) Example of the N2a appearance at 30 h post-transfection with control (E) and Ntng2-specific siRNA (F). Visualization was done
using MAP2 counterstaining (red).as found in the crystal structure (Figure S3). With typical
hydrogen bonds about 0.25 nm in length, Ser200 is not in-
teracting directly with NGL2, although allosteric effects
could still influence the netrin-G2 binding loops.
We tested all variants for function by overexpressing
wild-type (WT) and variant netrin-G2 constructs in HeLa
cells and assessing their presence at the cell surface
through the use of indirect immunofluorescence and
immunoblotting validation (Figure S4). All variants dis-
played substantially decreased cell surface expression as
compared to WT (Figures 3D–3E). Notably, some of these
variants had more cell surface expression compared to
others, suggesting that some netrin-G2 may still be local-
ized in these individuals. The variants may nevertheless
show deficient ligand-receptor binding or signaling since
we did not observe a clear association with cell surface
expression levels and clinical phenotype severity.The American JourGiven the decreased cell surface expression pattern
observed in all seven variants, we sought to determine
the more global effects of NTNG2 loss of function. Using
siRNA to target endogenous Ntng2 expression in mouse
N2A cells, we first confirmed that transfection with our
Ntng2-specific siRNA led to decreased expression with
quantitative polymerase chain reaction (Figure 4A). We
next assessed neurite outgrowth and found a significant
reduction for all parameters assessed, which included neu-
rite number, neurite length, and convex hull area—a
measurement used for measuring dendritic field (Figures
4B–4F). These findings demonstrate a potential mecha-
nism by which the NTNG2 variants may contribute to
pathological neurodevelopment.
Netrin signaling has been implicated in neurologic and
psychiatric disorders. For example, conditional Ntng1
knockout in distinct neuronal subtypes is associated withnal of Human Genetics 105, 1048–1056, November 7, 2019 1053
alterations in fear and anxiety-like behaviors in rodent
models, and abnormal expression of NTNG2 has been
found in the human brain in refractory epilepsy.15,16
Studies of Ntng2 and Ngl2 knockout mice have shown
that both types of mutant mice have an identical pheno-
type of lack of behavioral startle in response to acoustic
stimulus, with no structural abnormalities noted in the
inner ear.17 Single-nucleotide polymorphisms (SNPs) and
differential expression patterns of NTNG1 and NTNG2
have been associated with schizophrenia and bipolar disor-
der in humans.18–20 A de novo genomic rearrangement
involving NTNG1 was proposed to potentially cause fea-
tures of Rett syndrome in an isolated individual.21
Additionally, de novo missense variants in NTNG1 were re-
ported in two individuals with autism spectrum disorder.22
An in vitro study of variants in the histone demethylase
KDM5C (Lysine demethylase 5C [MIM: 314690]), which
is known to cause intellectual disability, showed that
NTNG2 seemed to be important in mediating effects on
neurite growth and length; these results are consistent
with our findings here.23 In fact, several clinical features,
in addition to intellectual disability, are shared between
these two disorders, including variable neurologic, behav-
ioral, and dysmorphic features. Extensive behavioral bat-
tery on Ntng2 knockout mice demonstrated marked
deficits in learning, memory, and visual and motor func-
tioning.24 Although NTNG2 does not appear to be neces-
sary for axon guidance, it has been shown to be important
in the laminar distribution of its receptors and synaptic
plasticity.25,26 A homozygous founder frameshift variant
in NTNG2 has recently been identified in eight individuals
from four families with a similar clinical phenotype, and
this further strengthens the evidence supporting the
pathogenicity of the variants presented here.27
Other genes involved in netrin signaling have also been
implicated in neurodevelopmental disorders in isolated
case reports, some of which have involved examples of de
novo variation.28 Specifically, variations in LRRC4C and
LRRC4 have both been associated with intellectual
disability and autism.29,30 Furthermore, functional work
in mice has shown that LRRC4 expression regulates
N-methyl-D-aspartate receptor (NMDAR)-dependent syn-
aptic plasticity and prevents autistic-like behaviors.31
LRRC4C and LRRC4have both been shown to be important
in hippocampal synapse formation and function.32,33 The
marked findings of severe intellectual disability and autistic
features in our cohort are particularly intriguing given the
unique role of NTNG2 in vertebrates. As we previously
mentioned, netrin-g family members express in distinct,
non-overlapping, and complementary neuronal circuits,
suggesting a role in establishing appropriate neuronal
patterning. This neuronal compartmentalization parallels
distinct behavioral compartmentalization, as in mouse
knockout models, Ntng2 knockouts demonstrated sensori-
motor, spatial memory, working memory, procedural
learning, and attentional deficits, while Ntng1 knockouts
demonstrated distinct learning and fear conditioning defi-1054 The American Journal of Human Genetics 105, 1048–1056, Novcits.24 Our findings here, in conjunction with the known
role ofNTNG2 in the control of synaptic plasticity andpost-
synapticmembraneorganization, illustrate the clinical rele-
vance of these neuronal functions to higher cognitive pro-
cesses. In fact, given the profound finding of intellectual
disability in the individuals presented here, it is intriguing
that NTNG2 expression is enriched in the human claus-
trum, an enigmatic brain region posited to play a role in
the integration of conscious perception.34
Our work provides the groundwork for establishing a
genotype-to-phenotype relationshipwithNTNG2 variants,
and establishes an initial description of the clinical spec-
trum. NTNG2 should be considered in the clinical evalua-
tion of children with severe intellectual disability and
neuropsychiatric symptoms. In addition to identification
by exome sequencing, it will be important to add NTNG2
to clinical gene-panel tests for intellectual disability given
the marked yet variable clinical phenotype. In summary,
our results implicate rare bi-allelic missense NTNG2 vari-
ants in the pathobiology of a neurodevelopmental disorder
consisting of severe intellectual disability, autistic features,
and motor impairment. Our findings provide strong clin-
ical and functional evidence for the importance of the
appropriate expression of NTNG2 in neurodevelopment.Accession Numbers
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